<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04240938</url>
  </required_header>
  <id_info>
    <org_study_id>Minia2020</org_study_id>
    <nct_id>NCT04240938</nct_id>
  </id_info>
  <brief_title>Adult Dacryocystocele Among Patients With Epiphora</brief_title>
  <official_title>Adult Encysted Dacryocystocele: Prevalence Among Patients With Epiphora and Its Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were
      done for them after their evaluation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation for lacrimal passage in the included patients using syringing, probing and dye
      disappearance test. Dacryocystorhinostomy were done for all patients and followed up for at
      least 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Adult Dacryocystocele</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patency of the lacrimal passage</measure>
    <time_frame>2 weeks</time_frame>
    <description>Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disappearance of lacrimal sac swelling</measure>
    <time_frame>1 month</time_frame>
    <description>No evident swelling in the medial side of the eye</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Lacrimal Passage Obstruction</condition>
  <arm_group>
    <arm_group_label>Lacrimal sac mucocele</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adult patients with lacrimal sac mucocele</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dacryocystorhinostomy</intervention_name>
    <description>Anastomosis between lacrimal sac and nasal cavity</description>
    <arm_group_label>Lacrimal sac mucocele</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lacrimal sac mucocele

          -  Acquired type

        Exclusion Criteria:

          -  No previous lacrimal sac surgery

          -  Suspected lacrimal sac malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed F Ibrahiem, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Minya</city>
        <state>Minia</state>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 21, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Mohamed Farag Khalil Ibrahiem</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lacrimal Apparatus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

